Ultragenyx Pharmaceutical Down over 45%, on Pace for Record Low Close and Record Percent Decrease

Dow Jones
Sep 03

Ultragenyx Pharmaceutical, Inc. (RARE) is currently at $14.40, down $12.13 or 45.72%

 

--Would be new all-time closing low (Based on available data back to Jan. 31, 2014)

--Would be largest percent decrease on record (Based on available data back to Jan. 31, 2014)

--Snaps a two day winning streak

--Down 37.39% year-to-date

--Down 91.88% from its all-time closing high of $177.39 on Dec. 23, 2020

--Down 53.96% from 52 weeks ago (Sept. 4, 2025), when it closed at $31.28

--Down 60.59% from its 52-week closing high of $36.54 on Dec. 4, 2025

--Would be a new 52-week closing low

--Traded as low as $13.81; new all-time intraday low (Based on available data back to Jan. 31, 2014)

--Down 47.95% at today's intraday low; largest intraday percent decrease on record (Based on available data back to Jan. 31, 2014)

 

All data as of 11:24:52 AM ET

 

Source: Dow Jones Market Data, FactSet

 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10